(Q80130214)
Statements
A Phase I and pharmacological study of the platinum polymer AP5280 given as an intravenous infusion once every 3 weeks in patients with solid tumors (English)
Jos H Beijnen
Jan H M Schellens
Jeany M Rademaker-Lakhai
Catherine Terret
Stephen B Howell
Christiane M Baud
Richard F De Boer
Dick Pluim
Jean-Pierre Droz